TrianglePUBLICATIONS · 22504925
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2012 May 24
- First author
- Kumar SK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kumar SK
- type
- Author
- name
- Hayman SR
- type
- Author
- name
- Buadi FK
- type
- Author
- name
- Roy V
- type
- Author
- name
- Lacy MQ
- type
- Author
- name
- Gertz MA
- type
- Author
- name
- Allred J
- type
- Author
- name
- Laumann KM
- type
- Author
- name
- Bergsagel LP
- type
- Author
- name
- Dingli D
- type
- Author
- name
- Mikhael JR
- type
- Author
- name
- Reeder CB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kumar SK
- type
- Author
- name
- Hayman SR
- type
- Author
- name
- Buadi FK
- type
- Author
- name
- Roy V
- type
- Author
- name
- Lacy MQ
- type
- Author
- name
- Gertz MA
- type
- Author
- name
- Allred J
- type
- Author
- name
- Laumann KM
- type
- Author
- name
- Bergsagel LP
- type
- Author
- name
- Dingli D
- type
- Author
- name
- Mikhael JR
- type
- Author
- name
- Reeder CB
- type
- Author
- bibliography ids
- nci-bib-00be7304d273802c422b54df
- book metadata
- content sha256
- ad814524d014dfd5149f4a78c2392ac2d058d7db5b50827b5d2c76275040b15b
- document type
- citation
- dois
- 10.1182/blood-2012-01-407791
- electronic publication date
- display
- 2012 Apr 13
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22504925
- immutable id
- pubmed:22504925@ad814524d014dfd5149f4a78c2392ac2d058d7db5b50827b5d2c76275040b15b
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 21
- name
- Blood
- nlm unique id
- 7603509
- pages
- 4860-7
- volume
- 119
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22504925
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 2a2d3297c342bb439d91ac496085d4250f0d9cd1eedd6197f1821c0e34f474c2
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 May 24
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.
Preserved source evidence · Not medical advice